Knowledge of disease and its Natural History is an essential element of any clinical development program. Real-World Data (RWD) is data relating to patient health status and/or the delivery of healthcare routinely collected from a variety of sources.
Under the right conditions, data derived from real world sources can be used to build Rare diseases Natural History to support regulatory decisions.
To learn more about how Boston Biotech Clinical Research can assist with your regulatory needs, we invite you to be in touch.
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.